The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Defining mild, moderate, and severe fatigue in cancer patients and survivors: E2Z02, a trial of the Eastern Cooperative Oncology Group.
Xin Shelley Wang
No relevant relationships to disclose
Fengmin Zhao
No relevant relationships to disclose
Michael Fisch
No relevant relationships to disclose
Tito R. Mendoza
No relevant relationships to disclose
Ann M. O'Mara
No relevant relationships to disclose
David Cella
Consultant or Advisory Role - Pfizer
Research Funding - Pfizer
Charles S. Cleeland
No relevant relationships to disclose